Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy.
暂无分享,去创建一个
S. Campo | A. D'Ascola | A. Avenoso | G. Campo | A. Saitta | A. Calatroni | M. Castaldo | A. Sardo | E. Giunta | A. D’Ascola
[1] Yan Shen,et al. Extensive Association Analysis Between Polymorphisms of PON Gene Cluster With Coronary Heart Disease in Chinese Han Population , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[2] P. Masson,et al. The active site of human paraoxonase (PON1) , 2001, Journal of applied toxicology : JAT.
[3] S. Reddy,et al. Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.
[4] B. L. Du,et al. Is Paraoxonase-3 Another HDL-Associated Protein Protective Against Atherosclerosis? , 2001 .
[5] D. Shih,et al. Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[6] P. Stetson,et al. Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation* , 2000, The Journal of Biological Chemistry.
[7] P. Durrington,et al. Human serum paraoxonase. , 1998, General pharmacology.
[8] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[9] P. Durrington,et al. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification , 1998, FEBS letters.
[10] P. Durrington,et al. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon , 1997, British journal of pharmacology.
[11] B. La Du,et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.
[12] A. Smolen,et al. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. , 1991, Drug metabolism and disposition: the biological fate of chemicals.